Beijing Centergate Technologies Holding Co Ltd
Beijing Centergate Technologies (holding) Co., Ltd. engages in the pharmaceutical industry in China and internationally. The company offers Anemarrhena saponin BII and capsules for vascular dementia treatment; Bifonazole API, an opioid receptor antagonist; Naloxone Hydrochloride injection to relieve acute ethanol poisoning; Naltrexone Hydrochloride tablets to block the pharmacological effects of … Read more
Beijing Centergate Technologies Holding Co Ltd (000931) - Net Assets
Latest net assets as of September 2025: CN¥1.87 Billion CNY
Based on the latest financial reports, Beijing Centergate Technologies Holding Co Ltd (000931) has net assets worth CN¥1.87 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.82 Billion) and total liabilities (CN¥1.95 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.87 Billion |
| % of Total Assets | 48.91% |
| Annual Growth Rate | 6.1% |
| 5-Year Change | -5.43% |
| 10-Year Change | 110.53% |
| Growth Volatility | 51.11 |
Beijing Centergate Technologies Holding Co Ltd - Net Assets Trend (1996–2024)
This chart illustrates how Beijing Centergate Technologies Holding Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Beijing Centergate Technologies Holding Co Ltd (1996–2024)
The table below shows the annual net assets of Beijing Centergate Technologies Holding Co Ltd from 1996 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.81 Billion | +4.03% |
| 2023-12-31 | CN¥1.74 Billion | +3.88% |
| 2022-12-31 | CN¥1.67 Billion | -7.79% |
| 2021-12-31 | CN¥1.81 Billion | -5.10% |
| 2020-12-31 | CN¥1.91 Billion | +2.90% |
| 2019-12-31 | CN¥1.86 Billion | -1.91% |
| 2018-12-31 | CN¥1.89 Billion | +5.73% |
| 2017-12-31 | CN¥1.79 Billion | +67.83% |
| 2016-12-31 | CN¥1.07 Billion | +24.30% |
| 2015-12-31 | CN¥858.30 Million | +23.99% |
| 2014-12-31 | CN¥692.22 Million | +8.95% |
| 2013-12-31 | CN¥635.38 Million | -23.43% |
| 2012-12-31 | CN¥829.77 Million | +4.79% |
| 2011-12-31 | CN¥791.81 Million | -9.49% |
| 2010-12-31 | CN¥874.85 Million | +1.85% |
| 2009-12-31 | CN¥858.96 Million | +7.55% |
| 2008-12-31 | CN¥798.63 Million | -12.37% |
| 2007-12-31 | CN¥911.32 Million | +38.29% |
| 2006-12-31 | CN¥659.01 Million | -1.00% |
| 2005-12-31 | CN¥665.70 Million | -44.03% |
| 2004-12-31 | CN¥1.19 Billion | -12.38% |
| 2003-12-31 | CN¥1.36 Billion | -33.17% |
| 2002-12-31 | CN¥2.03 Billion | -12.06% |
| 2001-12-31 | CN¥2.31 Billion | +8.50% |
| 2000-12-31 | CN¥2.13 Billion | +30.90% |
| 1999-12-31 | CN¥1.63 Billion | +253.88% |
| 1998-12-31 | CN¥459.59 Million | +16.21% |
| 1997-12-31 | CN¥395.47 Million | +14.84% |
| 1996-12-31 | CN¥344.36 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Beijing Centergate Technologies Holding Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 79636786100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CN¥753.13 Million | 47.42% |
| Other Components | CN¥1.63 Billion | 102.72% |
| Total Equity | CN¥1.59 Billion | 100.00% |
Beijing Centergate Technologies Holding Co Ltd Competitors by Market Cap
The table below lists competitors of Beijing Centergate Technologies Holding Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Yujin Robot Co. Ltd
KQ:056080
|
$356.98 Million |
|
INDIA SHELTER FINANCE CORPORATION LIMITED
NSE:INDIASHLTR
|
$357.03 Million |
|
Beijing Infosec Technologies Co. Ltd. A
SHG:688201
|
$357.07 Million |
|
Elior Group SA
OTCGREY:ELROF
|
$357.22 Million |
|
Niva Bupa Health Insurance Company Limited
NSE:NIVABUPA
|
$356.73 Million |
|
Contec Medical Systems Co Ltd
SHE:300869
|
$356.65 Million |
|
Shenzhen Kexin Communication Technologies Co Ltd
SHE:300565
|
$356.53 Million |
|
Kale Environmental Technology (Shanghai) Corporation
SHE:301070
|
$356.51 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Beijing Centergate Technologies Holding Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,535,226,464 to 1,588,370,940, a change of 53,144,476 (3.5%).
- Net income of 53,592,190 contributed positively to equity growth.
- Dividend payments of 28,846,054 reduced retained earnings.
- Other factors increased equity by 28,398,340.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥53.59 Million | +3.37% |
| Dividends Paid | CN¥28.85 Million | -1.82% |
| Other Changes | CN¥28.40 Million | +1.79% |
| Total Change | CN¥- | 3.46% |
Book Value vs Market Value Analysis
This analysis compares Beijing Centergate Technologies Holding Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.46x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 10.17x to 2.46x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1996-12-31 | CN¥0.51 | CN¥5.19 | x |
| 1997-12-31 | CN¥0.59 | CN¥5.19 | x |
| 1998-12-31 | CN¥0.68 | CN¥5.19 | x |
| 1999-12-31 | CN¥2.41 | CN¥5.19 | x |
| 2000-12-31 | CN¥2.51 | CN¥5.19 | x |
| 2001-12-31 | CN¥2.53 | CN¥5.19 | x |
| 2002-12-31 | CN¥2.26 | CN¥5.19 | x |
| 2003-12-31 | CN¥1.34 | CN¥5.19 | x |
| 2004-12-31 | CN¥1.50 | CN¥5.19 | x |
| 2005-12-31 | CN¥0.74 | CN¥5.19 | x |
| 2006-12-31 | CN¥0.76 | CN¥5.19 | x |
| 2007-12-31 | CN¥0.91 | CN¥5.19 | x |
| 2008-12-31 | CN¥0.93 | CN¥5.19 | x |
| 2009-12-31 | CN¥1.02 | CN¥5.19 | x |
| 2010-12-31 | CN¥1.04 | CN¥5.19 | x |
| 2011-12-31 | CN¥1.09 | CN¥5.19 | x |
| 2012-12-31 | CN¥1.13 | CN¥5.19 | x |
| 2013-12-31 | CN¥0.83 | CN¥5.19 | x |
| 2014-12-31 | CN¥0.93 | CN¥5.19 | x |
| 2015-12-31 | CN¥1.17 | CN¥5.19 | x |
| 2016-12-31 | CN¥1.31 | CN¥5.19 | x |
| 2017-12-31 | CN¥2.13 | CN¥5.19 | x |
| 2018-12-31 | CN¥2.24 | CN¥5.19 | x |
| 2019-12-31 | CN¥2.22 | CN¥5.19 | x |
| 2020-12-31 | CN¥2.26 | CN¥5.19 | x |
| 2021-12-31 | CN¥2.11 | CN¥5.19 | x |
| 2022-12-31 | CN¥1.97 | CN¥5.19 | x |
| 2023-12-31 | CN¥2.04 | CN¥5.19 | x |
| 2024-12-31 | CN¥2.11 | CN¥5.19 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Beijing Centergate Technologies Holding Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.37%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.12%
- • Asset Turnover: 0.68x
- • Equity Multiplier: 2.34x
- Recent ROE (3.37%) is above the historical average (-1.68%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1996 | 28.41% | 5.40% | 1.34x | 3.92x | CN¥63.41 Million |
| 1997 | 15.97% | 3.62% | 1.21x | 3.66x | CN¥23.62 Million |
| 1998 | 18.46% | 4.04% | 1.55x | 2.95x | CN¥38.89 Million |
| 1999 | 10.85% | 7.93% | 0.71x | 1.92x | CN¥13.74 Million |
| 2000 | 9.39% | 10.13% | 0.24x | 3.90x | CN¥-10.30 Million |
| 2001 | 4.99% | 4.46% | 0.20x | 5.68x | CN¥-85.37 Million |
| 2002 | -12.36% | -20.06% | 0.13x | 4.86x | CN¥-340.27 Million |
| 2003 | -70.24% | -106.16% | 0.08x | 8.27x | CN¥-723.39 Million |
| 2004 | 5.74% | 4.37% | 0.23x | 5.66x | CN¥-43.09 Million |
| 2005 | -106.46% | -105.04% | 0.10x | 9.71x | CN¥-581.18 Million |
| 2006 | 0.82% | 0.86% | 0.11x | 8.70x | CN¥-46.96 Million |
| 2007 | 14.47% | 3.99% | 0.47x | 7.66x | CN¥27.52 Million |
| 2008 | 9.69% | 2.94% | 0.51x | 6.43x | CN¥-1.95 Million |
| 2009 | 7.22% | 2.14% | 0.61x | 5.51x | CN¥-19.19 Million |
| 2010 | 1.49% | 0.40% | 0.65x | 5.71x | CN¥-59.82 Million |
| 2011 | 5.68% | 1.26% | 0.76x | 5.91x | CN¥-31.62 Million |
| 2012 | 3.93% | 0.91% | 0.78x | 5.51x | CN¥-46.22 Million |
| 2013 | -34.97% | -5.46% | 0.83x | 7.72x | CN¥-253.25 Million |
| 2014 | 2.19% | 0.45% | 1.21x | 4.00x | CN¥-49.07 Million |
| 2015 | 19.27% | 14.14% | 0.39x | 3.49x | CN¥73.32 Million |
| 2016 | 3.10% | 1.85% | 0.47x | 3.57x | CN¥-60.81 Million |
| 2017 | 0.89% | 0.82% | 0.48x | 2.29x | CN¥-145.09 Million |
| 2018 | 5.51% | 5.25% | 0.50x | 2.09x | CN¥-75.76 Million |
| 2019 | 5.70% | 4.46% | 0.60x | 2.14x | CN¥-71.93 Million |
| 2020 | 3.26% | 3.10% | 0.52x | 2.03x | CN¥-114.56 Million |
| 2021 | -6.31% | -5.12% | 0.53x | 2.33x | CN¥-258.62 Million |
| 2022 | -2.04% | -1.47% | 0.58x | 2.39x | CN¥-178.41 Million |
| 2023 | 3.16% | 2.13% | 0.60x | 2.46x | CN¥-104.95 Million |
| 2024 | 3.37% | 2.12% | 0.68x | 2.34x | CN¥-105.24 Million |
Industry Comparison
This section compares Beijing Centergate Technologies Holding Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,270,459,078
- Average return on equity (ROE) among peers: 14.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Beijing Centergate Technologies Holding Co Ltd (000931) | CN¥1.87 Billion | 28.41% | 1.04x | $356.80 Million |
| Blue Sail Medical Co Ltd (002382) | $10.54 Billion | 10.97% | 0.61x | $763.05 Million |
| Andon Health Co Ltd (002432) | $758.75 Million | 1.34% | 0.32x | $2.12 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $2.75 Billion | 15.67% | 0.82x | $346.13 Million |
| Guangzhou Improve Med Instrument (300030) | $592.55 Million | 4.90% | 0.10x | $234.74 Million |
| Shanghai Tofflon Science Tech (300171) | $2.41 Billion | 11.06% | 0.57x | $784.88 Million |
| Truking Technology Ltd (300358) | $320.32 Million | 29.77% | 1.35x | $545.42 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $1.41 Billion | 16.14% | 0.58x | $438.45 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $1.55 Billion | 13.64% | 0.15x | $1.62 Billion |
| Autek China Inc (300595) | $105.24 Million | 28.59% | 0.10x | $1.21 Billion |